HETEROCYCLES, Vol. 86, No. 2, 2012
1373
cm-1; 1H NMR (500 MHz, CDCl3, δ) 1.80 (s, 3H), 2.09 (m, 1H), 2.21 (m, 1H), 2.502.65 (m, 2H), 2.75 (d,
J = 4.3 Hz, 1H), 4.07 (dd, J = 5.7, 4.3 Hz, 1H), 4.59 (ddd, J = 7.3, 7.3, 5.7 Hz, 1H), 5.01 (m, 1H), 5.06 (m,
13
1H); C NMR (126 MHz, CDCl3, ) 18.3, 24.0, 28.4, 77.6, 81.5, 114.3, 142.6, 177.1; HRMS-ESI (m/z)
[M+Na]+ Calcd for C8H12O3Na: 179.0679, Found: 179.0674.
Barton‒McCombie-type transformation via the thiocarbonate (+)-12. A mixture of (+)-11 (13.1 mg,
0.0839 mmol), DMAP (30.8 mg, 0.252 mmol), and o-phenylchlorothionoformate (17 µL, 0.126 mmol) in
MeCN (0.84 mL) was stirred at room temperature for 17 h. After the evaporation of the solvent, the
residue was purified by silica gel column chromatography (CHCl3/MeCN = 50/1) to afford (+)-12 (22.6
mg, 92%). Compound (+)-12: []D +91.5 (c 0.14, CHCl3); IR (neat) 2924, 1774, 1188, 1103, 748 cm-1;
1H NMR (500 MHz, CDCl3, δ) 1.87 (s, 3H), 2.12 (m, 1H), 2.33 (m, 1H), 2.532.67 (m, 2H), 4.83 (ddd, J
= 7.3, 7.3, 6.0 Hz, 1H), 5.20 (m, 1H), 5.22 (m, 1H), 5.72 (d, J = 6.0 Hz, 1H), 7.12 (d, J = 7.7 Hz, 2H),
7.30 (dd, J = 7.4, 7.4 Hz, 1H), 7.42 (dd, J = 7.7, 7.4 Hz, 2H); 13C NMR (126 MHz, CDCl3, ) 19.2, 24.0,
28.0, 79.0, 87.2, 117.6, 121.8, 121.8, 126.7, 129.6, 129.6, 137.8, 153.3, 176.1, 194.0; HRMS-ESI (m/z)
[M+Na]+ Calcd for C15H16O4SNa: 315.0662, Found: 315.0662.
A mixture of (+)-12 (22.6 mg, 0.0773 mmol), tributyltin hydride (13 µL, 0.101 mmol), and
azobisisobutyronitrile (1.3 mg, 0.00792 mmol) in toluene (0.77 mL) was stirred at 100 C for 5.5 h. After
the evaporation of the solvent, the residue was purified by column chromatography (10% w/w anhydrous
K2CO3-silica;17 hexane/EtOAc = 5/1) to afford a 1:1 mixture of 13 and 14 (8.0 mg, 68%). Compound
13: 1H NMR (300 MHz, CDCl3, δ) 1.74 (d, J = 1.1 Hz, 3H), 1.78 (d, J = 1.0 Hz, 3H), 1.93 (m, 1H), 2.36
(m, 1H), 2.55 (m, 2H), 5.22 (m, 1H), 5.22 (m, 1H); 13C NMR (126 MHz, CDCl3, ) 18.3, 25.7, 29.1, 29.3,
1
77.6, 122.8, 139.8, 177.2. Compound 14: H NMR (300 MHz, CDCl3, δ) 1.78 (s, 3H), 1.91 (m, 1H),
2.262.38 (m, 2H), 2.452.57 (m, 3H), 4.66 (dddd, J = 14.4, 13.4, 7.7, 6.7 Hz, 1H), 4.80 (m, 1H), 4.88
(m, 1H); 13C NMR (126 MHz, CDCl3, ) 22.8, 27.6, 28.6, 43.4, 79.1, 113.7, 140.4, 177.0.
Synthesis of ()-15. A mixture of (+)-11 (55.2 mg, 0.353 mmol), tetrabromomethane (211 mg, 0.636
mmol), and triphenylphosphine (166 mg, 0.634 mmol) in CH2Cl2 (3.5 mL) was stirred at room
temperature for 3.5 h. After the evaporation of the solvent, the residue was purified by silica gel column
chromatography (hexane/EtOAc = 3/1) to afford ()-15 (52.4 mg, 68%). Compound ()-15: []D 17.2
1
(c 1.00, CHCl3); IR (neat) 1782, 640 cm-1; H NMR (500 MHz, CDCl3, δ) 1.90 (s, 3H), 2.17 (m, 1H),
13
2.522.67 (m, 3H), 4.48 (d, J = 8.9 Hz, 1H), 4.73 (m, 1H), 5.06 (m, 1H), 5.18 (m, 1H); C NMR (126
MHz, CDCl3, ) 18.0, 27.0, 28.5, 59.3, 79.2, 117.5, 140.9, 176.1; HRMS-ESI (m/z) [M+Na]+ Calcd for
C8H1179BrO2Na: 240.9835, Found: 240.9840; HRMS-ESI (m/z) [M+Na]+ Calcd for C8H1181BrO2Na: